Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3065% above fair value
$37.68−1.49 (-3.80%)
Close on Nov 17, 2026Market cap $49.54BP/E –Yield –
Medline price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Medline
Medline has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?